Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool October 19, 2005 Stephen D. Simpson	ICU, You Look Healthier An incredible third quarter shows what operating leverage can do for this little medical technology company. Investors, take note.
The Motley Fool April 20, 2006 Stephen D. Simpson	More Predictable Unpredictability at ICU Hidden beneath all of the volatility is a pretty decent med-tech business. Recent volatility was the kind that investors like. The stock spiked up as earnings exceeded analyst estimates and the business did a fair bit better than management had projected at the end of last quarter.
The Motley Fool December 10, 2010 Sean Williams	ICU Medical: Bargain or Value Trap? International sales growth will be the key to the medical supplier's long-term success.
The Motley Fool July 19, 2005 Stephen D. Simpson	Peek-a-Boo ICU ICU Medical has taken on quite a bit of risk in the process of remaking the company. It's best to wait for a reasonable valuation before buying shares.
The Motley Fool November 10, 2005 Stephen D. Simpson	Hospitable Treatment for Hospira Solid margins fuel strong earnings at the hybrid generics - medical distributor. Buying this stock wisely may be the key to good long-term returns.
The Motley Fool August 26, 2005 Stephen D. Simpson	OmniVision's Margins of Error Can this semiconductor firm's projected strong revenue growth combat sagging margins? Investors, take note.
The Motley Fool January 18, 2012 Sean Williams	Are These 2 Medical Device Makers Takeover Targets? Could these two medical device makers put themselves up for sale in 2012?
The Motley Fool August 18, 2004 Jeff Hwang	Is Applied Materials Losing Momentum? The company posted a strong third quarter, but a less optimistic outlook has its shares near its 52-week low.
The Motley Fool November 5, 2007 Brian Orelli	Can't Beat BD's Steady Growth Fourth-quarter results offer more of the same steady growth for medical technology company Becton, Dickinson.
The Motley Fool July 13, 2011	ICU Medical Earnings Preview Medical systems maker ICU Medical will unveil its latest earnings on Monday, July 18. Investors never know what to expect for the company, as it has wavered between topping and missing analysts estimates during the past fiscal year.
The Motley Fool October 20, 2005 Stephen D. Simpson	Baxter Needs Growth Infusion This is a fine health-care company, but a sluggish top line suggests there are limits to how far it can go. Trading at nearly 20 times forward earnings, it seems like expectations of a growth revival are already in the stock.
The Motley Fool May 12, 2008 Chuck Saletta	How to Compete Successfully Against Giants Small businesses have an opening they can use to profit from opportunities the giants leave behind.
The Motley Fool April 27, 2005 Stephen D. Simpson	Becton, Dickinson's Boring Reliability This broadly diversified medical device company doesn't grow fast, but it is consistent. Investors looking for a stable and dependable company with broad exposure to the medical industry should take a look for themselves at Becton, Dickinson.
The Motley Fool May 13, 2005 Brian Gorman	Hospira's Hopeful Signs The medical products company's strong quarter belies a less exciting future. Investors should probably take a wait-and-see attitude.
The Motley Fool November 9, 2006 Brian Lawler	Hospira's Flatlining Sales There's no good news to be found in this medical products supplier's medicine chest. The upcoming fourth quarter isn't going to be any better, either. Investors, take note.
The Motley Fool March 15, 2006 Rich Smith	Foolish Forecast: New York, New Year Analysts are looking for clothier New York & Co. to hit the top of its latest guidance of $0.33 to $0.36 per share for the quarter. That 9% increase might be a bit optimistic, however, in light of the already confirmed "revenue miss."
The Motley Fool July 20, 2007 Brian Orelli	Baxter's Mixed Message A recall of Baxter BioScience's COLLEAGUE infusion pumps seems to have over-shadowed healthy quarterly earnings reports.
The Motley Fool November 3, 2005 Stephen D. Simpson	Becton, Dickinson: More Boring Growth This company may seem to be just a collection of boring businesses making things like syringes, reagents, and safety products. But shareholders aren't feeling too bored with today's strong stock performance.
The Motley Fool February 23, 2011 Cindy Johnson	Fear of the Future Outweighs HP's Great Quarter Did this tech titan's stock deserve to get slammed?
The Motley Fool October 13, 2010 Seth Jayson	From Gross to Net at Becton Dickinson With recent margins exceeding historical averages, medical device company Becton Dickinson looks like it's doing fine.
The Motley Fool May 9, 2006 Stephen D. Simpson	Riding the Hospira Yo-Yo There's a solid foundation on this roller coaster pharmaceutical and drug delivery company. Maybe Hospira's current valuation doesn't make it a "gem," but that's not really within its control.
The Motley Fool August 10, 2006 Stephen D. Simpson	Volatility, Thy Name Is Hospira Margins continue to stand in the way of consistent performance at the health-care company. Investors, take note.
The Motley Fool September 19, 2007 Rich Smith	Foolish Forecast: Progress May Be Delayed In advance of earnings reports, management has raised revenue guidance, but unfortunately, not profits guidance.
The Motley Fool April 18, 2008 Brian Orelli	Recalls Can't Beat Baxter In spite of charges for two recalls, Baxter posts a decent quarter.
BusinessWeek May 31, 2004 Robert Barker	Hospira Just May Put You In The Pink If the Abbott Laboratories spin-off's first steps hardly seem promising, that's one reason why I see the company as worth much more of the intelligent investor's attention than the long calendar of pending tech and biotech IPOs.
The Motley Fool July 22, 2009 Chris Jones	Are These Winners Worth the Risk? Will medical device and supply stocks keep posting big gains?
The Motley Fool June 9, 2005 Richard Gibbons	Buying on Margins Profit margins are one useful tool for finding great stock values.
The Motley Fool April 20, 2006 Stephen D. Simpson	Baxter Bags Better Margins This is a great business -- but only at the right price. Investors, this story has to be bought cheap. At today's prices, is it cheap enough?
The Motley Fool April 22, 2005 Brian Gorman	Baxter Is on the Mend The medical products company continues to right itself for a brighter future. The firm's long-term positioning and diversified business may make it worth a closer look.
The Motley Fool July 27, 2007 Brian Orelli	Stability From a Likely Source Becton Dickinson's earnings are solid. The medical device and lab supply company has reported growth in earnings and increases in margins.
The Motley Fool October 19, 2007 Brian Orelli	Baxter Gets Pumped Up Medical-device maker Baxter puts in a nice quarter despite two recent FDA recalls.
The Motley Fool January 20, 2011 Jeremy Phillips	Time to Sell Hospira? Hospira has failed two of the quick tests that would make it a sell. This is great, but does it mean you should hold your Hospira shares?
The Motley Fool August 17, 2005 David Meier	The Power of Margins The way you think about margins can give you an investing edge.
The Motley Fool October 31, 2011 Rebecca Lipman	Earnings Surprises: Short-Sellers Think These Stocks Are Going Higher Short-sellers appear to think the upside potential of these names outweigh the downside. What do you think?
The Motley Fool January 19, 2012 Rebecca Lipman	Investing 101: Are Short-Sellers Underestimating These Companies? Interested in contrarian investing ideas?
The Motley Fool March 1, 2007 Brian Lawler	Hospira's Boring Growth The medical products provider announces its fourth quarter financial results and gives guidance for 2007. Investors, take note.
The Motley Fool September 24, 2008 Brian Orelli	Hey, You! Stop! The FDA has ordered Baxter and Hospira to stop making their ophthalmic balanced salt solutions within 60 days.